Castel V - Search Results

1

Precision medicine in Ewing sarcoma: a translational point of view.

Gargallo P, Juan A, Yáñez Y, Dolz S, Segura V, Castel V, Cañete A. Gargallo P, et al. Among authors: castel v. Clin Transl Oncol. 2020 Sep;22(9):1440-1454. doi: 10.1007/s12094-020-02298-7. Epub 2020 Feb 5. Clin Transl Oncol. 2020. PMID: 32026343 Review.

2

[Malignant lymphoma in children. Medium- and long-term course].

Castel V, Cañete A. Castel V, et al. An Esp Pediatr. 1990 Nov;33 Suppl 43:154-5. An Esp Pediatr. 1990. PMID: 2103987 Spanish. No abstract available.

3

Long-term follow-up and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institution.

Aparicio J, Munárriz B, Pastor M, Vera FJ, Castel V, Aparisi F, Montalar J, Badal MD, Gómez-Codina J, Herranz C. Aparicio J, et al. Among authors: castel v. Oncology. 1998 Jan-Feb;55(1):20-6. doi: 10.1159/000011841. Oncology. 1998. PMID: 9428371

4

A novel TP53 germ-line mutation identified in a girl with a primitive neuroectodermal tumor and her father.

Orellana C, Martínez F, Hernandez-Marti M, Castel V, Cañete A, Prieto F, Badía L. Orellana C, et al. Among authors: castel v. Cancer Genet Cytogenet. 1998 Sep;105(2):103-8. doi: 10.1016/s0165-4608(98)00015-6. Cancer Genet Cytogenet. 1998. PMID: 9723024

5

Surgical treatment for neuroblastoma: complications during 15 years' experience.

Cañete A, Jovani C, Lopez A, Costa E, Segarra V, Fernández JM, Verdeguer A, Velázquez J, Castel V. Cañete A, et al. Among authors: castel v. J Pediatr Surg. 1998 Oct;33(10):1526-30. doi: 10.1016/s0022-3468(98)90490-0. J Pediatr Surg. 1998. PMID: 9802806

6

Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.

Castel V, García-Miguel P, Cañete A, Melero C, Navajas A, Ruíz-Jiménez JI, Navarro S, Badal MD. Castel V, et al. Eur J Cancer. 1999 Apr;35(4):606-11. doi: 10.1016/s0959-8049(98)00395-5. Eur J Cancer. 1999. PMID: 10492635

7

Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients.

Cañete A, Navarro S, Bermúdez J, Pellín A, Castel V, Llombart-Bosch A. Cañete A, et al. Among authors: castel v. J Clin Oncol. 2000 Jan;18(1):27-34. doi: 10.1200/JCO.2000.18.1.27. J Clin Oncol. 2000. PMID: 10623690

8

Results of the cooperative protocol (N-III-95) for metastatic relapses and refractory neuroblastoma.

Castel V, Cañete A, Melero C, Acha T, Navajas A, García-Miguel P, Contra T, Molina J, Galarón P, Cruz O. Castel V, et al. Med Pediatr Oncol. 2000 Dec;35(6):724-6. doi: 10.1002/1096-911x(20001201)35:6<724::aid-mpo53>3.0.co;2-u. Med Pediatr Oncol. 2000. PMID: 11107156 Clinical Trial.

9

Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results.

Castel V, Cañete A, Navarro S, García-Miguel P, Melero C, Acha T, Navajas A, Badal MD. Castel V, et al. Med Pediatr Oncol. 2001 Dec;37(6):537-42. doi: 10.1002/mpo.1248. Med Pediatr Oncol. 2001. PMID: 11745893 Clinical Trial.

10

Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation.

Carvajal E, Verdeguer A, Fernández JM, Cañete A, Castel V. Carvajal E, et al. Among authors: castel v. J Pediatr Hematol Oncol. 2001 Dec;23(9):626-8. doi: 10.1097/00043426-200112000-00016. J Pediatr Hematol Oncol. 2001. PMID: 11902311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters